Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors

Näytä muut versiot (1)

<strong>Objective:</strong> Antipsychotic drug efficacy may have decreased over the decades. We, therefore, present a comprehensive meta-analysis of all placebo-controlled trials in acute schizophrenia, we investigate which trial characteristics have changed over the years and which ones...

Bibliografiset tiedot
Päätekijät:	Leucht, S, Leucht, C, Huhn, M, Chaimani, A, Mavridis, D, Helfer, B, Samara, M, Rabaioli, M, Bächer, S, Cipriani, A, Geddes, J, Salanti, G, Davis, J
Aineistotyyppi:	Journal article
Julkaistu:	American Psychiatric Publishing 2017

Samankaltaisia teoksia

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors.
Tekijä: Leucht, S, et al.
Julkaistu: (2017)

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response
Tekijä: Leucht, S, et al.
Julkaistu: (2018)

Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis
Tekijä: Leucht, S, et al.
Julkaistu: (2019)

Efficacy of antipsychotic drugs for schizophrenia - Authors' reply.
Tekijä: Leucht, S, et al.
Julkaistu: (2013)

Initial Severity of Schizophrenia and Efficacy of Antipsychotics: Participant-Level Meta-analysis of 6 Placebo-Controlled Studies.
Tekijä: Furukawa, T, et al.
Julkaistu: (2015)

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
Tekijä: Leucht, S, et al.
Julkaistu: (2013)

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis
Tekijä: Leucht, S, et al.
Julkaistu: (2013)

Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article
Tekijä: Chaimani, A, et al.
Julkaistu: (2017)

The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia.
Tekijä: Spineli, L, et al.
Julkaistu: (2013)

The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia
Tekijä: Spineli, L, et al.
Julkaistu: (2013)

Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
Tekijä: Maximilian Huhn, et al.
Julkaistu: (2022-06-01)

Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?
Tekijä: Leucht, S, et al.
Julkaistu: (2018)

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Tekijä: Huhn, M, et al.
Julkaistu: (2019)

Network meta-analyses should be the highest level of evidence in treatment guidelines
Tekijä: Leucht, S, et al.
Julkaistu: (2016)

Comparative efficacy and tolerability of 31 oral and long-acting injectable antipsychotics for maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis
Tekijä: Schneider-Thoma, J, et al.
Julkaistu: (2022)

Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis
Tekijä: Salanti, G, et al.
Julkaistu: (2018)

Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review
Tekijä: Furukawa, T, et al.
Julkaistu: (2016)

Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies
Tekijä: Samara, MT, et al.
Julkaistu: (2017)

Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy.
Tekijä: Furukawa, T, et al.
Julkaistu: (2018)

DSM-III-R change in definition might have affected placebo response to antidepressants - Authors' reply
Tekijä: Cipriani, A, et al.
Julkaistu: (2017)

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Tekijä: Geddes, J, et al.
Julkaistu: (2000)

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies
Tekijä: Furukawa, T, et al.
Julkaistu: (2016)

Allowing for uncertainty due to missing and LOCF imputed outcomes in meta‐analysis
Tekijä: Mavridis, D, et al.
Julkaistu: (2018)

Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis.
Tekijä: Spineli, L, et al.
Julkaistu: (2013)

Are the results of open randomised controlled trials comparing antipsychotic drugs in schizophrenia biased? Exploratory meta- and subgroup analysis
Tekijä: Stefan Leucht, et al.
Julkaistu: (2024-02-01)

A fully Bayesian application of the Copas selection model for publication bias extended to network meta-analysis.
Tekijä: Mavridis, D, et al.
Julkaistu: (2013)

Atypical antipsychotics in the treatment of schizophrenia: Systematic review, meta-regression and evidence-based treatment recommendations
Tekijä: Geddes, J, et al.
Julkaistu: (2000)

Commentary on strategies for switching antipsychotics
Tekijä: Leucht Stefan, et al.
Julkaistu: (2008-06-01)

Authors' reply
Tekijä: Leucht, S, et al.
Julkaistu: (2013)

Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials
Tekijä: Johannes Schneider-Thoma, et al.
Julkaistu: (2021-08-01)

Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
Tekijä: Georgia Salanti, et al.
Julkaistu: (2023-02-01)

An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios.
Tekijä: Efthimiou, O, et al.
Julkaistu: (2014)

An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios
Tekijä: Efthimiou, O, et al.
Julkaistu: (2014)

Graphical tools for network meta-analysis in STATA.
Tekijä: Anna Chaimani, et al.
Julkaistu: (2013-01-01)

A living meta-ecological study of the consequences of the COVID-19 pandemic on mental health
Tekijä: Leucht, S, et al.
Julkaistu: (2021)

Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta-analysis
Tekijä: McCutcheon, RA, et al.
Julkaistu: (2022)

Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis
Tekijä: Spyridon Siafis, et al.
Julkaistu: (2020-08-01)

Living systematic review and meta-analysis of plasma-concentrations of antipsychotic drugs in carriers and non-carriers of variant CYP450 genotypes: Living systematic review protocol [version 2; peer review: 2 approved]
Tekijä: Stefan Leucht, et al.
Julkaistu: (2024-07-01)

The treatment of schizophrenia - the state of the evidence
Tekijä: Leucht Stefan
Julkaistu: (2008-04-01)

Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis
Tekijä: Lena Feber, et al.
Julkaistu: (2023-03-01)